Coronavirus Infections: Clinical Trials

4598 completed, 2141 unknown, 586 terminated, 404 withdrawn. 1960 Not applicable, 1512 Phase 2, 959 Phase 3, 722 Phase 1, 264 Phase 4.

By phase and status

Phase	Trials	Status
Not applicable	1960	Completed 1190, Unknown 436, Withdrawn 83, Recruiting 79, Terminated 78, Active not recruiting 50, Not yet recruiting 27, Enrolling by invitation 9, Suspended 8
Phase 2	1512	Completed 691, Unknown 334, Terminated 255, Withdrawn 139, Recruiting 43, Active not recruiting 27, Not yet recruiting 12, Suspended 8, Enrolling by invitation 3
Phase 3	959	Completed 426, Unknown 242, Terminated 149, Withdrawn 88, Recruiting 22, Active not recruiting 13, Suspended 11, Not yet recruiting 6, Enrolling by invitation 2
Phase 1	722	Completed 403, Unknown 149, Terminated 71, Withdrawn 56, Recruiting 20, Active not recruiting 13, Not yet recruiting 10
Phase 4	264	Completed 121, Unknown 83, Terminated 27, Withdrawn 14, Recruiting 9, Active not recruiting 5, Suspended 3, Not yet recruiting 2
Early Phase 1	65	Unknown 24, Completed 23, Terminated 6, Withdrawn 5, Suspended 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1

Follow Coronavirus Infections: new trials by email Literature Review of Coronavirus Infections trials Research Report on Coronavirus Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Perceptions of Undergraduate Students and Teaching Staff on Online Teaching Questionnaire - Covid19		Suspended	Misr International University	9209	2027-07-15	2026-10-08
Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms IV infusion using an isolated, placental, mesenchymal stem cell derived EVs, Placebo IV administration - COVID-19	Phase 1 / Phase 2	Not yet recruiting	Kimera Labs Inc.	64	2027-01-01	2026-06-24
Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition	Phase 1 / Phase 2	Not yet recruiting	University of Alberta	30	2026-12-30	2026-10-16
CD19-B Cell Depletion in PAIS-ME/CFS Patients Inebilizumab, Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID)	Phase 2	Not yet recruiting	Charite University, Berlin, Germany	38	2026-12-01	2026-07-24
Dapagliflozin for Long COVID Syndrome Dapagliflozin (DAPA), Placebo - COVID - 19, Long COVID Syndrome	Phase 3	Not yet recruiting	Ottawa Heart Institute Research Corporation	192	2026-12-01	2026-10-30
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS AVM0703, Placebo - ARDS, Covid19	Phase 1	Not yet recruiting	AVM Biotechnology Inc	16	2026-12-01	2026-11-02
Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections Baseline MxA testing, Serial MxA testing, MxA result feedback and antiviral treatment recommendations - Respiratory Viral Infections, Influenza	Not applicable	Not yet recruiting	Capital Medical University	618	2026-11-30	2026-10-23
Pancoronavirus Vaccine Study in Healthy Adults Ages 18-55 Cov-RBD-scNP-001, ACU-026-001-1 - Coronavirus Infection	Phase 1	Not yet recruiting	Duke University	36	2026-11-16	2026-10-29
The Study of Brave-LC LDN Treatment Trial naltrexone, Placebo - Post-acute COVID-19 Syndrome	Phase 3	Not yet recruiting	National Institute of Allergy and Infectious Diseases (NIAID)	1300	2026-11-16	2026-11-04
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) Keytruda - Post-Acute COVID-19 Syndrome	Phase 1	Not yet recruiting	National Institute of Neurological Disorders and Stroke (NINDS)	15	2026-11-10	2026-11-05
Fatigue in Long COVID Lightning Process, Activity Pacing - Long COVID	Not applicable	Not yet recruiting	McMaster University	100	2026-11-01	2026-07-13
Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test Flu A/B/COVID-19 + RSV Multiplex Rapid Test - SARS-CoV-2 Infection, Influenza A	Not applicable	Not yet recruiting	CorDx, Inc.	1500	2026-11-01	2026-10-15
Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France Region Vaccination Coverage Among Pregnant Women		Not yet recruiting	Assistance Publique - Hôpitaux de Paris	1605	2026-11-01	2026-10-20
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction Valacyclovir, Celecoxib, Paxlovid - Post-acute Sequelae of COVID-19, Long COVID	Phase 2	Recruiting	Icahn School of Medicine at Mount Sinai	150	2026-10-20	2026-10-28
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine RVX-sCPD9 - COVID -19	Phase 1	Not yet recruiting	National Institute of Allergy and Infectious Diseases (NIAID)	80	2026-10-17	2026-10-30
Epigenetic Changes in Long COVID Patients Long COVID-19 Syndrome, Long COVID Symptoms		Active not recruiting	Istituti Clinici Scientifici Maugeri SpA	1000	2026-10-12	2026-11-04
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations mRNA-1273, mRNA-1283 - SARS-CoV-2	Phase 4	Recruiting	ModernaTX, Inc.	600	2026-10-09	2026-11-04
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study Cryotherapy - ME/CFS, Fibromyalgia (FM)	Not applicable	Recruiting	Oxford Brookes University	40	2026-10-05	2026-11-05
Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE) Aripiprazole (low-dose, 1mg), Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID-19 Condition (PCC or Long COVID)	Phase 2	Not yet recruiting	Christiana Franke	138	2026-10-01	2026-07-20
ELderly REspiratory VIral Cohort Respiratory viral infection - Influenza Viruses, Respiratory Syncytial Virus (RSV)		Not yet recruiting	Assistance Publique - Hôpitaux de Paris	1000	2026-10-01	2026-09-10

Showing 20 of 8358. Sign in to see all of them.

Narrower conditions

COVID-19 (7572)  ·  Post-Acute COVID-19 Syndrome (599)  ·  Severe Acute Respiratory Syndrome (357)  ·  Respiratory Distress Syndrome (227)  ·  Pneumonia (221)  ·  Anxiety Disorders (182)  ·  Virus Diseases (150)  ·  Depression (133)  ·  Influenza, Human (126)  ·  Respiratory Insufficiency (124)  ·  Motor Activity (110)  ·  Pneumonia, Viral (109)  ·  Fatigue (95)  ·  Infections (89)

Broader conditions

Nidovirales Infections (8337)  ·  Coronaviridae Infections (8330)  ·  RNA Virus Infections (8327)  ·  Infections (8269)  ·  Virus Diseases (8208)  ·  Respiratory Tract Diseases (8084)  ·  Respiratory Tract Infections (8006)  ·  Lung Diseases (7978)  ·  Pneumonia, Viral (7869)  ·  Pneumonia (7771)  ·  Pathological Conditions, Signs and Symptoms (1616)  ·  Pathologic Processes (1290)  ·  Disease Attributes (912)  ·  Chronic Disease (665)

Interventions

Standard of Care (182)  ·  Hydroxychloroquine (175)  ·  Surveys and Questionnaires (119)  ·  Blood Specimen Collection (116)  ·  BNT162 Vaccine (110)  ·  Sodium Chloride (90)  ·  COVID-19 Vaccines (88)  ·  remdesivir (80)  ·  Saline Solution (79)  ·  2019-nCoV Vaccine mRNA-1273 (73)  ·  Ivermectin (70)  ·  Azithromycin (65)  ·  sinovac COVID-19 vaccine (57)  ·  Exercise (49)  ·  tocilizumab (49)

Sponsors

Assistance Publique - Hôpitaux de Paris (121)  ·  Assiut University (80)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (74)  ·  Pfizer (67)  ·  University Hospital, Strasbourg, France (58)  ·  Duke University (44)  ·  University Hospital, Montpellier (44)  ·  AstraZeneca (38)  ·  Cairo University (38)  ·  ModernaTX, Inc. (36)  ·  Ain Shams University (34)  ·  Hospices Civils de Lyon (32)  ·  Mayo Clinic (32)  ·  Stanford University (30)  ·  BioNTech SE (29)

Countries

United States (2014)  ·  France (806)  ·  China (454)  ·  Turkey (Türkiye) (439)  ·  Spain (437)  ·  Italy (398)  ·  United Kingdom (374)  ·  Brazil (338)  ·  Canada (311)  ·  Egypt (259)  ·  Germany (258)  ·  Mexico (204)  ·  Belgium (183)  ·  Russia (163)  ·  Argentina (128)

Top investigators

Mike Royal, MD (16)  ·  Adrian Hernandez, MD (9)  ·  Susanna Naggie, MD (8)  ·  Mikhail Samsonov (7)  ·  Neha Sharma (7)  ·  Sabine Hazan, MD (7)  ·  Tao Huang (7)

Results publications

PMID 34473343, PMID 35244208, PMID 31986264, PMID 35713300, PMID 32031570, PMID 32109013, PMID 32091533, PMID 32171076, PMID 34013969, PMID 36734509, PMID 37162745, PMID 33502773, PMID 36695483, PMID 34658014, PMID 37489818, PMID 37591523, PMID 32167524, PMID 34350582, PMID 32192578, PMID 32250385, PMID 32007143, PMID 32105632, PMID 32142651, PMID 33044747, PMID 33757717, PMID 38597249, PMID 33306989, PMID 33570583, PMID 36435633, PMID 32020029, PMID 32085846, PMID 32205204, PMID 32738928, PMID 33240091, PMID 33301246, PMID 34425070, PMID 35695334, PMID 39903535, PMID 15616839, PMID 21435708, PMID 27344959, PMID 31978945, PMID 31995857, PMID 32105637, PMID 32112977, PMID 32125452, PMID 32219428, PMID 32251768, PMID 32445440, PMID 32678530

NIH funding

2023 (21), U24TR001608 (8), 2025 (5), R25MH071584 (5), 1OT2HL156812-01 (4), P30CA033572 (4), OT2HL156812 (3), P30CA138292 (3), R01MD016328 (3), 1OT2HD107558-01 (2), 3UL1TR002538-03S2 (2), 3UM1AI068614-14S1 (2), 5UM1AI068614-14 (2), 5UM1AI148373-05 (2), 5UM1AI148684-02 (2)